Compound information
- Natural Products
- NACP62969
- Molecular Formula
- C17H22O4
- Molecular Weight
- 290.151809184 g/mol
- Structure
-
- IUPAC Name
- 1-(4-hydroxy-3-methoxy-phenyl)dec-1-ene-3,5-dione
- InChI
- InChI=1S/C17H22O4/c1-3-4-5-6-14(18)12-15(19)9-7-13-8-10-16(20)17(11-13)21-2/h7-11,20H,3-6,12H2,1-2H3
- InChI Key
- JUKHKHMSQCQHEN-UHFFFAOYSA-N
- SMILES
- O=C(C=CC1=CC=C(O)C(OC)=C1)CC(=O)CCCCC
- CAS
- 76060-35-0
- SuperClass
- Phenylpropanoids and polyketides
- Class
- Cinnamic acids and derivatives
- SubClass
- Hydroxycinnamic acids and derivatives
- Source
- CNP0223356
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 1 |
Heteroatom Count | 4 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 63.6 Å2 | LogP | 3.02 |
LogS | -4.711 | LogD | 2.804 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.838 | Pgp substrate | 0.002 |
HIA | 0.964 | F20 % | 0.86 |
F30 % | 0.483 | Caco-2 | -4.736 |
MDCK | -4.577 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.992 | PPB | 52.615 |
VD | 1.026 | Fu | 0.755 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.862 | CYP1A2 substrate | 0.577 |
CYP2A6 substrate | 0.493 | CYP2B6 substrate | 0.626 |
CYP2C19 inhibitor | 0.178 | CYP2C19 substrate | 0.736 |
CYP2C8 substrate | 0.685 | CYP2C9 inhibitor | 0.258 |
CYP2C9 substrate | 0.07 | CYP2D6 inhibitor | 0.011 |
CYP2D6 substrate | 0.186 | CYP2E1 substrate | 0.228 |
CYP3A4 inhibitor | 0.08 | CYP3A4 substrate | 0.123 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.969 | CL | 13.061 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.049 | Hepatotoxicity | 0.348 |
Mutagenicity | 0.232 | Rat Oral Acute Toxicity | 0.245 |
FDAMDD | 0.369 | Skin Sensitization | 0.995 |
Carcinogenicity | 0.194 | Eye Corrosion | 0.005 |
Eye Irritation | 0.933 | Respiratory Toxicity | 0.873 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.787 | IGC50 | 5.293 |
LC50FM | 5.818 | LC50DM | 4.751 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.338 | NR-AR-LBD | 0.665 |
NR-AhR | 0.299 | NR-Aromatase | 0.116 |
NR-ER | 0.677 | NR-ER-LBD | 0.409 |
NR-PPAR-gamma | 0.853 | SR-ARE | 0.121 |
SR-ATAD5 | 0.717 | SR-HSE | 0.729 |
SR-MMP | 0.617 | SR-p53 | 0.431 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.